-
PRODUCTS AND SERVICES
【Hot data】 Resmetirom (MGL-3196) evaluation data available in STAM modelNEW!!
2024.03.26
As you may already know, the United States Food and Drug Administration (FDA) announced the approval of Rezdiffra (resmetirom), developed by Madrigal Pharmaceuticals, as the first treatment for MASH.
-
NEWS RELEASE
【Breaking News!】 First MASH treatment approved by FDANEW!!
2024.03.22
On March 14th, The United States Food and Drug Administration (FDA) announced their approval of Rezdiffra (resmetirom), developed by Madrigal Pharmaceuticals, as the first treatment for MASH.
-
PRODUCTS AND SERVICES
2024.03.14
If you are considering a drug evaluation study for liver cancer using a mouse model, our STAM™-HCC/IO⁺ model best replicates the pathology and characteristics seen in human patients with liver cancer, which allows for the optimal evaluation of your compound's efficacy.